Work

A phase I study of etirinotecan pegol in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.3_suppl.550

Authors: Smitha S. Krishnamurthi, Manpreet Chadha, Mary Beth Rodal, Glen J. Weiss, Joseph A. Bokar, Gayle S. Jameson, Catherine Patricia Mast, Carol Zhao, Bridget Waluch, Ute Hoch, Alison Hannah, Afshin Dowlati, Neal J. Meropol, Ramesh K. Ramanathan

Institutions: University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Translational Genomics Research Institute, Nektar Therapeutics (United States)

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590664985

Cites:

Cited by: 1

Related to: 10